In the second quarter of the financial year, Glenmark Pharmaceuticals reported numbers that were broadly in line with analysts` estimates. Its revenue surged 17% year-on-year, driven by a stellar 30% growth in its US business and 21% growth in the domestic business. The robust improvement in the US
5.08 PM Nov 23rd
Glenmark Pharmaceuticals Ltd has announced the following results for the quarter ended September 30, 2013: The Unaudited results for the Quarter ended September 30, 2013 The Company has posted a net profit of Rs. 1059.48 million for the quarter ended September 30, 2013 as compared to Rs. 1373
5.29 PM Oct 31st
Source:Economic Times - NEW DELHI: Drugmaker Glenmark Pharmaceuticals has put on the block its oral contraceptive product division which makes the generic anti-pregnancy medicine and sells it in the American market, two persons familiar with the development told ET. The company promoted by Glenn
1.24 PM Oct 3rd
Follow moneycontrol.comFacebook Twitter Google Plus RSS Wap SMS SMS Alert iPad iPhone Blackberry OVI Android Window
Copyright © e-Eighteen.com Ltd. All rights reserved. Reproduction of news articles, photos, videos or any other content in whole or in part in any form or medium without express written permission of moneycontrol.com is prohibited.